Abstract: A ruthenium(II)-arene complex with picolinic acid, [(η 6 -p-cymene)RuCl(pico)]·H 2 O, was prepared by the reaction of [(η 6 -p-cymene)RuCl 2 ] 2 with picolinic acid in a 1:2 molar ratio in 2-propanol. The compound was characterized by elemental analysis, and IR and NMR spectroscopy. X-ray diffraction analysis showed that the molecule adopts a "three-leg piano-stool" geometry, which is common for this type of complexes. The cytotoxic activity of the complex was tested in two human cancer cell lines HeLa (cervix) and FemX (melanoma) by MTT assay. The IC 50 values were at 82.0 and 36.2 µmol dm -3 for HeLa and FemX cells, respectively.
INTRODUCTION
The structures and chemical properties of metal complexes of some pyridine carboxylates have been widely investigated. [1] [2] [3] [4] [5] Picolinic acid (2-pyridinecarboxylic acid) is a biologically important ligand incorporated into some enzymes, and it is an active agent in some drugs as well. [6] [7] [8] [9] [10] [11] It is also catabolite of L-tryptophan detected in the human body. 12, 13 Picolinates are used as dietary supplements. In particular, the chromium(III) complex reduces diabetes risk and therefore is used as a dietary supplement for obese people. 14 Zinc picolinate revealed an effect in the oxidant-antioxidant balance in patients with chronic obstructive pulmonary disease. 15 Alkaline picolinates inhibit the growth of Escherichia coli. 16, 17 Platinum complexes with picolinic acid have been synthesized and screened for cytotoxic activity. 18 
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In recent years, ruthenium complexes have gained much attention [19] [20] [21] [22] [23] in attempts to overcome the downsides of platinum complexes. Organometallic complexes and half-sandwich complexes of Ru(II) emerged as promising scaffolds for anticancer drug design. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] They often show aqueous solubility along with the necessary lipophilicity. The electronic system of the arene ligand stabilizes the metal in its lower oxidation state and also provides a hydrophobic face in the complex, which might enhance transport of ruthenium through cell membranes. In addition, ruthenium compounds possess good cytotoxic activity, while not notably affecting normal cells. 36, 37 One aspect of the action of ruthenium complexes is their ability to bind with the serum proteins: transferrin and albumin. 38 Tumor cells are more susceptible to ruthenium complexes due to an increased demand for iron and therefore there is an increased number of transferrin receptors on their surface. 39, 40 In addition, because ruthenium can mimic iron in binding to carrier proteins, its excess can be removed from cells, which is the reason for lower toxicity of ruthenium complexes compared to platinum complexes. 39 Recently, two series of Ru(II)-arene complexes with functionalized pyridines were described of the general formulae [(η 6 -p-cymene)Ru(XY)Cl] and [(η 6 -p--cymene)Ru(X)Cl 2 ], where XY were the mono-anionic N,O-bidentates 2,3-pyridine-, 2,4-pyridine-, 2,5-pyridine-and 2,6-pyridine-dicarboxylate, while X were monodentate ligands 3-acetylpyridine, 4-acetylpyridine, 2-amino-5-chloropyridine, isonicotinic or nicotinic acid bound to ruthenium(II) via the pyridine nitrogen. 41 Herein the X-ray diffraction structure of [(η 6 -p-cymene)Ru(pico)Cl] and its antiproliferative activity in two human cancer cell lines (cervix HeLa and melanoma Femx) are reported. Since the introduction of picolinate into a metal complex can result in enhanced activity, 42, 43 the aim of this work was to compare the activities of the prepared complex with previously described analogue complexes. 41 It should be noted that the complex was previously described but its Xray diffraction structure has not hitherto been reported. 44 
EXPERIMENTAL

Materials and measurements
Picolinic acid was purchased from Acros Organics and used without further purification. [(η 6 -p-Cymene)RuCl 2 ] 2 was prepared according to a published procedure. 45 Elemental analysis was realized using an Elemental Vario EL III microanalyzer. The infrared spectra were recorded on a Nicolet 6700 FT-IR spectrometer using the attenuated total reflectance (ATR) technique. The 1 H-and 13 C-NMR spectra of the ligand and the complex were recorded on a Varian Gemini 200 instrument. Chemical shifts were referenced to residual 1 H and 13 C present in deuterated dimethyl sulfoxide.
Synthesis of the complex
To a warm solution of [(η 6 -p-cymene)RuCl 2 ] 2 (0.100 g, 0.16 mmol) in 2-propanol (25 cm 3 ) was added a solution of picolinic acid (0.046 g, 0.35 mmol) in 2-propanol (5 cm 3 ). The RUTHENIUM(II)-ARENE COMPLEXES 55 mixture was stirred at room temperature for 7 days and then kept in refrigerator until the product precipitated. The yellow-orange product was filtered off, washed with several drops of 2-propanol and then diethyl ether and dried in air. A crystal suitable for X-ray analysis was obtained by the slow evaporation of the mother liquor.
Crystallographic structure determination
The measurement was performed on a Bruker X8 APEXII CCD diffractometer. A single crystal was positioned at 35 mm from the detector and 941 frames were measured, each for 30 s over a 1° scan width. The data were processed using SAINT-Plus software. 46 The crystal data, data collection parameters and structure refinement details are given in Table I . The structure was solved by direct methods and refined by full-matrix least-squares techniques. Non-hydrogen atoms were refined with anisotropic displacement parameters. The H atoms were placed at calculated positions and refined as riding atoms in the subsequent least-squares model refinements. The isotropic thermal parameters were estimated to be 1.2 or 1.5 times (methyl groups) the values of the equivalent isotropic thermal parameters of the non-hydrogen atoms to which the hydrogen atoms were bonded. The following software programs, personal computer and tables were used: structure solution, SHELXS-97, 47 
where n is the number of reflections and p is the total number of parameters refined.
Cytotoxicity
Cell culture. Human cervix carcinoma cells (HeLa) and human melanoma cells (FemX) were maintained as monolayer cultures in Roswell Park Memorial Institute (RPMI) 1640 nutrient medium (Sigma Chemicals Co, USA). The RPMI 1640 nutrient medium was prepared in sterile deionized water, supplemented with penicillin (192 U ml -1 ), streptomycin (200 μg ml -1 ), 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) (25 mM), L-glutamine (3 mM) and 10 % heat-inactivated fetal calf serum (FCS) (pH 7.2). The cells were grown at 37 °C in a 5 % CO 2 humidified air atmosphere.
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Cytotoxicity assay. The drug-induced cytotoxicity was determined using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma) assay. 51 Cells were seeded in 96-well cell culture plates (NUNC), HeLa (2000 c/w) and FemX (2000 c/w), in culture medium and grown for 24 h. A stock solution of the complex was prepared in DMSO at a concentration of 30 mM and subsequently diluted with nutrient medium to the desired final concentrations (in the range up to 300 µM).
Solutions of various concentrations of the examined compound were added to the wells, except for the control wells where only the nutrient medium was added. All samples were prepared in triplicate. Nutrient medium with corresponding agent concentrations but without the target cells was used as the blank, also in triplicate. The cells were incubated with the test compound for 48 h at 37 °C, in a 5 % CO 2 humidified air atmosphere. After incubation, 20 µl of MTT solution, 5 mg mL -1 in phosphate buffer solution (PBS), pH 7.2, were added to each well. The samples were incubated for 4 h at 37 °C in a 5 % CO 2 humidified air atmosphere. Formazan crystals were dissolved in 100 µL 10 % sodium dodecyl sulfate (SDS) in 0.01 M HCl. The absorbance was recorded on an enzyme-linked immunosorbent assay (ELISA) reader after 24 h at a wavelength of 570 nm. The IC 50 (µM) was defined as the concentration of drug producing 50 % inhibition and was determined from cell survival diagrams.
RESULTS AND DISCUSSION
Synthesis
The reaction of [(η 6 -p-cymene)RuCl 2 ] 2 with picolinic acid in a 1:2 molar ratio in 2-propanol at room temperature leads to the formation of the complex 
Spectroscopy
[(η 6 -p-Cymene)RuCl(pico)]·H 2 O exhibits an asymmetric stretching vibration ν as (COO -) at 1637 cm −1 . Picolinic acid revealed an analogous vibration of the free carboxylic group at 1718 cm −1 . The difference in frequency is due to coordination of the ligand through one of the oxygen atoms of the carboxylic group and nitrogen atom of the pyridine ring, and is consistent with the X-ray diffraction structure.
The 1 H NMR spectrum of the complex contains a characteristic pattern for the p-cymene moiety. A methyl group singlet is seen at 2.15 ppm, the resonance signal of -CH(CH 3 ) 2 appears as a multiplet at 2.72 ppm and -CH(CH 3 ) 2 
X-Ray crystallography
The structure of [(η 6 -p-cymene)RuCl(pico)]·H 2 O was confirmed by X-ray diffraction. The complex crystallized in the monoclinic space group Pn and has the typical "three-leg piano-stool" geometry well-documented for a large number of ruthenium(II) and osmium(II) arene complexes, and in particular, for the closely related compounds [(η 6 -1,3,5-Me 3 C 6 H 3 )RuCl(pico)] 52 and [(η 6 -p-cymene) 2 OsCl(pico)], 42 with the η 6 π-bound arene ring forming the seat and the picolinate ligand bound via a nitrogen and one carboxylic oxygen, with one chloride ligand as the legs of the piano-stool. Selected bond lengths and angles are given in the legend to Fig. 1 
Cytotoxic activity
The antiproliferative activity of the prepared complex was assayed in two human cancer cell lines HeLa (cervix) and FemX (melanoma) by the MTT assay. The tumor cells were incubated for 48 h with the investigated complex. The results of these tests indicate that the complex after 48 h of incubation exhibited cytotoxic activity with IC 50 81.97 µM for HeLa cells and 36.23 µM for FemX cells. These values are the mean of 2 to 3 independent experiments, whereby the standard deviations were less than 15 %. The results of representative experiments are shown in Fig. 2 . Data are representative for one out of two to three separate experiments with standard deviation.
